BIOMAT Database Logo BIOMAT Database Logo

Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors. 2012

Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44, West Culture Road, 250012 Jinan, Shandong, PR China.

In continuation of our efforts toward the discovery of potent HIV-1 NNRTIs with novel structures, we have employed a scaffold hopping strategy to explore the chemically diversed space of bioactive compounds. The original arylazolylthioacetanilide platform was replaced with different imidazopyridinylthioacetanilide scaffolds to yield the optimal pharmacophore moieties in order to generate novel NNRTIs with desirable potency. Some of the new compounds proved able to inhibit HIV-1 replication in the low micromolar range. In particular, compound 5b16 displayed the most potent anti-HIV-1 activity (EC(50) = 0.21 ± 0.06 μM), inhibiting HIV-1 IIIB replication in MT-4 cells more effectively than dideoxycytidine (EC(50) = 1.4 ± 0.1 μM) and similarly with nevirapine (EC(50) = 0.20 ± 0.10 μM). Preliminary structure-activity relationship (SAR) of the newly synthesized congeners is discussed, and molecular modeling study is performed to rationalize the SAR conclusions.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000083 Acetanilides Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA. Acetylanilines,N-Phenylacetamides
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors.
January 2007, Bioorganic & medicinal chemistry,
Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Design, synthesis and biological evaluation of novel molecules as potent PARP-1 inhibitors.
September 2021, Bioorganic & medicinal chemistry letters,
Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs.
February 2019, Bioorganic & medicinal chemistry,
Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Design, Synthesis and Biological Evaluation of Novel Substituted N,N'-Diaryl ureas as Potent p38 Inhibitors.
September 2015, Molecules (Basel, Switzerland),
Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Design, synthesis and biological evaluation of novel substituted benzoylguanidine derivatives as potent Na+/H+ exchanger inhibitors.
June 2009, Bioorganic & medicinal chemistry letters,
Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs.
June 2021, Bioorganic & medicinal chemistry,
Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors.
March 2012, Bioorganic & medicinal chemistry letters,
Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Design, synthesis and biological evaluation of substituted (+)-SG-1 derivatives as novel anti-HIV agents.
June 2018, Bioorganic & medicinal chemistry letters,
Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Design, synthesis and biological evaluation of novel 3-substituted pyrazolopyrimidine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors.
May 2018, Bioorganic & medicinal chemistry,
Xiao Li, and Peng Zhan, and Hong Liu, and Dongyue Li, and Liu Wang, and Xuwang Chen, and Huiqing Liu, and Christophe Pannecouque, and Jan Balzarini, and Erik De Clercq, and Xinyong Liu
Design, synthesis, and biological evaluation of novel molecules as potent inhibitors of PLK1.
October 2023, Bioorganic chemistry,
Copied contents to your clipboard!